Outcomes of Left Ventricular Assist Device for Patients with Hypertrophic Cardiomyopathy
Kota Suzuki(The University of Osaka), Yoshiki Sawa(Osaka Police Hospital), Köichi Toda(The University of Osaka), Shigeru Miyagawa(The University of Osaka), Satoshi Kainuma(National Cerebral and Cardiovascular Center), Ai Kawamura(Max Planck Institute for Heart and Lung Research), Daisuke Yoshioka(The University of Osaka), Hiroaki Hata(Nihon University), Takuji Kawamura(The University of Osaka), Y. Yoshikawa(The University of Osaka), Takaaki Samura(Fukui CardioVascular Center)
Cited by 0
Related Papers
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction
|Nature Medicine|1997|589
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
|Circulation Journal|2020|363
Thoracic and cardiovascular surgeries in Japan during 2018
|General Thoracic and Cardiovascular Surgery|2020|123
Comparison of Febuxostat and Allopurinol for Hyperuricemia in Cardiac Surgery Patients (NU-FLASH Trial)
|Circulation Journal|2013|120